SBC Medical Group
SBC
13 hedge funds and large institutions have $18.8M invested in SBC Medical Group in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 29 closing their positions.
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
50.07% less ownership
Funds ownership: 83.62% → 33.55% (-50%)
66% less funds holding
Funds holding: 38 → 13 (-25)
82% less capital invested
Capital invested by funds: $106M → $18.8M (-$87.6M)
86% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Crystalline Management
Montreal, Quebec,
Canada
|
+$2.18M |
| 2 |
Walleye Capital
New York
|
+$1.49M |
| 3 |
Walleye Trading
New York
|
+$837K |
| 4 |
TCM
Tuttle Capital Management
Riverside,
Connecticut
|
+$297K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$136K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$10.7M |
| 2 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$8.56M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$8.2M |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$7.83M |
| 5 |
ASM
ATW SPAC Management
New York
|
-$5.17M |
SBC Hedge Fund Activity: Q2 2023 in Review
13 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group (SBC) for Q2 2023, worth a combined $18.8M — down 82% from $106M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of SBC and 4 opened new positions — a net loss of 25 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Crystalline Management, adding an estimated $2.18M. The largest seller was Periscope Capital, exiting entirely with an estimated $10.7M sold.
- 13 institutional investors held SBC Medical Group (SBC) as of Q2 2023, down from 38 in Q1 2023.
- Funds reported $18.8M of SBC Medical Group stock for Q2 2023, down 82% quarter-over-quarter.
- 4 funds opened new SBC Medical Group positions in Q2 2023 and 29 closed out, a net change of -25 holders.
- The largest SBC Medical Group buyer in Q2 2023 was Crystalline Management, an estimated $2.18M added.
- The largest SBC Medical Group seller in Q2 2023 was Periscope Capital, an estimated $10.7M sold.
Based on aggregated 13F filings for Q2 2023.